Jonasch, Eric http://orcid.org/0000-0003-0943-2806
Song, Yan
Freimark, Jonathan
Berman, Richard
Nguyen, Ha
Signorovitch, James
Sundaram, Murali
Funding for this research was provided by:
Merck Sharp & Dohme LLC (Merck Sharp & Dohme LLC)
Article History
Received: 20 June 2023
Accepted: 3 February 2024
First Online: 16 February 2024
Declarations
:
: Data were de-identified and comply with the patient requirements of the Health Insurance Portability and Accountability Act (HIPAA) of 1996; therefore, no reviews by an institutional review board were required.
: Not applicable.
: YS, JF, and JS are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, which funded the development and conduct of this study and manuscript. RB and HN were employees of Analysis Group, Inc. at the time of study conduct. MS is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. EJ has received research funding from Arrowhead, Merck, and NiKang as well as honoraria from Aveo, Aravive, Calithera, Eisai, Exelixis, Ipsen, Merck, NiKang, Novartis, Pfizer, and Takeda.